Nencki Institute of Experimental Biology of Polish Academy of Sciences, 3 Pasteur Str., 02-093, Warsaw, Poland.
Nencki Institute of Experimental Biology of Polish Academy of Sciences, 3 Pasteur Str., 02-093, Warsaw, Poland.
Biochem Biophys Res Commun. 2024 Nov 19;734:150793. doi: 10.1016/j.bbrc.2024.150793. Epub 2024 Oct 8.
Alzheimer's disease (AD) is a tauopathy characterized by the deposition of amyloid aggregates of hyperphosphorylated Tau protein and amyloid-β peptide (Aβ) in the brain. Nevertheless, a soluble, oligomeric forms of Tau and Aβ are considered to be the most neurotoxic species responsible for neurodegenerative processes in AD. The mechanism of action of these oligomers remains largely unclear. Previously, we demonstrated the inhibition of the large-conductance calcium-activated potassium channel (BK) by Aβ. Therefore, in the present study we investigated the effect of Tau protein on the BK activity. Furthermore, since prion protein (PrP) interacts with Tau and the N-terminal fragment of PrP, called N1, can be neuroprotective in tauopathies, we checked whether N1 can also act at the level of BK channel. In the studies we used monomers, oligomers and amyloid fibrils of aggregation-prone Tau fragment, called K18, carrying tauopathy-associated mutation - deletion of Lys280 (K18Δ280). Additionally, to induce formation of neurotoxic oligomers, K18Δ280 was phosphorylated by protein kinase A (PKA). The activity of the plasma membrane BK of hippocampal neurons was recorded using single-channel patch-clamp technique in both inside-out and outside-out modes, exposing the cytosolic or extracellular surface of the membrane, respectively. In the outside-out mode - performing the extracellular application of the neurotoxic oligomers of phosphorylated K18Δ280, we observed a significant and concentration-dependent decrease in the probability of opening (Po) of BK. The Po of BK was fully recovered after washing the oligomers out. In the case of the inside-out patch-clamp configuration, we found that the Po of BK was not affected by the oligomers. In contrast to the oligomers, the monomers and amyloid fibrils of K18Δ280 had no effect on the channel activity, analyzed in inside-out as well as outside-out modes. Noteworthy, upon incubation with N1, the oligomers did not inhibit BK channel. The BK channel inhibition, dependent on the outside-out membrane orientation, implies specific interaction of the oligomers with the extracellular part of the channel. Moreover, our results suggest that N1 can convert the neurotoxic oligomers of Tau into a form which is not able to inhibit the channel, and indicate novel possible neuroprotective mechanism of PrP action in AD and other tauopathies.
阿尔茨海默病(AD)是一种以 Tau 蛋白过度磷酸化和淀粉样-β肽(Aβ)在脑内沉积为特征的 Tau 病。然而,可溶性寡聚体形式的 Tau 和 Aβ 被认为是最具神经毒性的物质,负责 AD 中的神经退行性过程。这些寡聚物的作用机制在很大程度上仍不清楚。先前,我们证明了 Aβ 抑制大电导钙激活钾通道(BK)。因此,在本研究中,我们研究了 Tau 蛋白对 BK 活性的影响。此外,由于朊病毒蛋白(PrP)与 Tau 相互作用,并且 PrP 的 N 端片段,称为 N1,在 Tau 病中具有神经保护作用,因此我们检查了 N1 是否也可以在 BK 通道水平发挥作用。在研究中,我们使用了携带 Tau 病相关突变 - 赖氨酸 280 缺失(K18Δ280)的易聚集 Tau 片段 K18 的单体、寡聚体和淀粉样纤维。此外,为了诱导形成神经毒性寡聚体,K18Δ280 被蛋白激酶 A(PKA)磷酸化。使用单通道膜片钳技术在内外模式下记录海马神经元质膜 BK 的活性,分别暴露细胞质或细胞膜外表面。在膜外模式下 - 对磷酸化 K18Δ280 的神经毒性寡聚体进行细胞外应用,我们观察到 BK 的开放概率(Po)显著且浓度依赖性降低。寡聚体洗涤后,BK 的 Po 完全恢复。在膜内片钳配置的情况下,我们发现寡聚体对 BK 的 Po 没有影响。与寡聚体相反,K18Δ280 的单体和淀粉样纤维对通道活性没有影响,无论是在膜内还是膜外模式下进行分析。值得注意的是,在与 N1 孵育后,寡聚体不抑制 BK 通道。依赖于膜外模式的 BK 通道抑制表明寡聚体与通道的细胞外部分的特异性相互作用。此外,我们的结果表明,N1 可以将 Tau 的神经毒性寡聚体转化为不能抑制通道的形式,并表明 PrP 在 AD 和其他 Tau 病中的神经保护作用的新的可能机制。